SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 108.26+0.1%Nov 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (984)4/17/1999 2:36:00 AM
From: Troll_29  Read Replies (2) of 3202
 
I agree with your analysis but this is precisely why it makes increasing sense for the big pharma's to use their $45 mil to buy into the threat of the future rather than a lame directionless attempt at competition.

I am long INCY and spoke with another investor yesterday. We played the following game... First question: What can derail INCY? After 2 hours we came up with - Nothing other than a buyout. Second question: Why is the obvious (to us) potential of INCY not reflected in the price? Answer: Either my/our understanding of INCY's business model is totally flawed or most analyst's understanding of INCY are flawed. It appears few/no analysts follow INCY at this point. I would appreciate any help on these questions.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext